Volume 63, Issue 10 pp. 2873-2883
Rheumatoid Arthritis

Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA–DRB1*0401–positive humanized mice and rheumatoid arthritis patients

Omri Snir

Omri Snir

Karolinska Institutet, Stockholm, Sweden

Mr. Snir and Ms Reick contributed equally to this work.

Search for more papers by this author
Mary Rieck

Mary Rieck

Benaroya Research Institute at Virginia Mason, Seattle, Washington

Mr. Snir and Ms Reick contributed equally to this work.

Search for more papers by this author
John A. Gebe

John A. Gebe

Benaroya Research Institute at Virginia Mason, Seattle, Washington

Search for more papers by this author
Betty B. Yue

Betty B. Yue

Benaroya Research Institute at Virginia Mason, Seattle, Washington

Search for more papers by this author
Crystal A. Rawlings

Crystal A. Rawlings

Benaroya Research Institute at Virginia Mason, Seattle, Washington

Search for more papers by this author
Gerald Nepom

Gerald Nepom

Benaroya Research Institute at Virginia Mason, Seattle, Washington

Search for more papers by this author
Vivianne Malmström

Corresponding Author

Vivianne Malmström

Karolinska Institutet, Stockholm, Sweden

Rheumatology Unit, Department of Medicine, Center for Molecular Medicine, CMM L8:04, Karolinska Institutet, SE-17176 Stockholm, SwedenSearch for more papers by this author
Jane H. Buckner

Jane H. Buckner

Benaroya Research Institute at Virginia Mason, Seattle, Washington

Search for more papers by this author
First published: 12 May 2011
Citations: 132

Abstract

Objective

Antibodies toward the citrullinated form of the synovial antigen vimentin are specific for rheumatoid arthritis (RA) and are associated with HLA–DRB1*0401. This suggests that T cells specific for peptides derived from citrullinated vimentin presented in the context of HLA–DRB1*0401 may contribute to the etiopathogenesis of RA. The aim of this study was to identify immunodominant epitopes from citrullinated vimentin presented by HLA–DRB1*0401 and to characterize the resulting T cell responses.

Methods

We first predicted an HLA-binding T cell epitope from citrullinated vimentin based on the binding motif of HLA–DRB1*0401 and then confirmed its affinity. A class II major histocompatibility complex (MHC) tetramer loaded with the citrullinated form of vimentin aa 59–78 (cit-vimentin aa 59–78) was constructed and used to screen for specific T cells in HLA–DRB1*0401–transgenic mice, patients with RA, and healthy control subjects. Additionally, the cytokine output following cit-vimentin aa 59–78 challenge was analyzed in patients and healthy control subjects by multicolor flow cytometry and Luminex-based analysis.

Results

The citrullinated form of vimentin aa 59–78 bound to HLA–DRB1*0401, but the native form could not. Subsequently, cit-vimentin aa 59–78–specific T cells were detected in immunized mice and in the periphery of both HLA–DR*0401–positive healthy control subjects and HLA–DR*0401–positive patients with RA, using class II MHC tetramers, CD154 up-regulation, and intracellular cytokine measurements. As demonstrated in cell culture supernatants, the production of cytokines (predominantly interferon-γ) in response to cit-vimentin aa 59–78 was significantly higher in patients compared with controls.

Conclusion

Here, we describe a posttranslational modification of an RA candidate autoantigen toward which HLA–DRB1*0401–restricted T cells can be detected in both patients with RA and healthy controls but for which a proinflammatory response is observed uniquely in patients with RA.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me